These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4168537)

  • 1. Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate.
    James VH; Munro DD; Feiwel M
    Lancet; 1967 Nov; 2(7525):1059-61. PubMed ID: 4168537
    [No Abstract]   [Full Text] [Related]  

  • 2. [Topical treatment of selected skin and mucosal diseases with betamethasone 17-valerate].
    Michalowski R; Kucharska D
    Pol Tyg Lek; 1973 Nov; 28(46):1822-4. PubMed ID: 4771862
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind clinical comparisons of topical betamethasone valerate and betamethasone benzoate in the treatment of steroid-responsive dermatoses.
    Hall-Smith P
    Br J Clin Pract; 1972 Sep; 26(9):422-3. PubMed ID: 4562674
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous absorption of a corticosteroid (betamethasone valerate) in combination with an antibiotic (gentamicin).
    Tonkin M; Politzer WM; Robinson RG
    S Afr Med J; 1966 Dec; 40(44):1071-2. PubMed ID: 5957107
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenal and pituitary functions during long-term topical steroid therapy.
    Hendrikse JC; Moolenaar AJ
    Dermatologica; 1972; 144(3):179-86. PubMed ID: 4640839
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of localized skin lesions with betamethasone 17-valerate and triamcinolone acetonide in alcoholic solution under occlusive dressing. A double blind comparative study.
    Neering H; van der Kroon HV; Roeleveld CG
    Dermatologica; 1972; 145(6):395-9. PubMed ID: 4571883
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative clinical study of betamethasone-17-valerate cream and fluocortolone-fluocortolone-21-capronate cream].
    Pfitzer G; Schröter R
    Hautarzt; 1971 Jul; 22(7):299-305. PubMed ID: 4398241
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pituitary-adrenal reserve after prolonged treatment with dexamethasone in some skin diseases].
    Witoszyński S; Janicka D
    Przegl Dermatol; 1969; 56(3):281-6. PubMed ID: 4310066
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect on adrenal axis function of topically applied betamethasone valerate ointment 0.1%.
    Fischer GO
    Australas J Dermatol; 1983 Apr; 24(1):26-32. PubMed ID: 6312951
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the systemic effect of extensively applied topical steroids].
    Holzmann H; Morsches B; Gebhardt R
    Arztl Forsch; 1972 May; 26(5):171-7. PubMed ID: 5068154
    [No Abstract]   [Full Text] [Related]  

  • 12. [Celestoderm in the therapy of certain skin diseases].
    Trofimova LIa; Nikitina MM; Makovoz VI; Ievleva EA; Chistiakova IA
    Vestn Dermatol Venerol; 1973 May; 47(5):74-7. PubMed ID: 4755969
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical studies on the stimulation and suppression of the pituitary-adrenocortical system. 3. Studies on the pituitary adrenocortical suppression after long-term glucocorticoid treatment].
    Sako Y
    Nihon Naibunpi Gakkai Zasshi; 1968 Dec; 44(9):1025-36. PubMed ID: 4304529
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenal function during topical oral corticosteroid treatment.
    Lehner T; Lyne C
    Br Med J; 1969 Oct; 4(5676):138-41. PubMed ID: 4309863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of percutaneously absorbed steroids on hypothalamic--pituitary--adrenal function after intensive use in in-patients.
    Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():67-76. PubMed ID: 1268079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of a new corticosteroid for dermatologic use: betamethasone 17-valerate].
    Témime P; Privat Y
    Sem Hop; 1965 May; 41(25):1523-5. PubMed ID: 4284389
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with a new topical corticosteroid, betamethasone 17-valerate.
    Hecht RA
    IMJ Ill Med J; 1968 Jul; 134(1):64-5 passim. PubMed ID: 4385640
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical corticosteroid therapy and its effect on the hypothalamic-pituitary-adrenal axis.
    Munro DD
    Dermatologica; 1976; 152 Suppl 1():173-80. PubMed ID: 782954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the pituitary-adrenal system in humans evaluated by the metyrapone test and gas-liquid chromatography estimation of urinary 17-OHCS during and after oral administration of prednisolone-21-stearoylglycolate and othe glucocorticoids.
    Sacchetti G; Tosolini G; Ezechieli S; Bergamini N
    Arzneimittelforschung; 1968 Mar; 18(3):336-9. PubMed ID: 5696010
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of intranasal betamethasone-17-valerate on perennial rhinitis and adrenal function.
    Czarny D; Brostoff J
    Lancet; 1968 Jul; 2(7561):188-90. PubMed ID: 4173404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.